Stock overview
Arrowhead Pharmaceuticals Inc.
Explore the company, reported ownership, price history, and available source evidence.
ARROWHEAD PHARMACEUTICALS INC (ARWR) is a listed warrant, unit, right, or acquisition-company security tracked from 13F filings.
- Last close
- $65.92
- · ARWR
- Tracked holders
- 4 funds
- Latest available 13F per fund
ARWR · USD
Price
$65.92
+$0.36
(+0.55%)
over selected range
Close · Sep 25, 2026
Market open
1255 stored daily closes
$65.92
Sep 25, 2026
- Range low
- $9.99
- Range high
- $89.59
- Observations
- 1255
- Session date
- Sep 25, 2026
Sep 27, 2021–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | — | $162,431,742 | 0.81% |
| Renaissance Technologies position history Q2 2026 · filed Aug 13, 2026 · SEC filing | −55% 26'Q2 | $38,221,751 | 0.05% |
| Gotham Asset Management position history Q2 2026 · filed Aug 14, 2026 · SEC filing | −83% 26'Q2 | $545,791 | 0% |
| Polen Capital Management position history Q2 2026 · filed Aug 4, 2026 · SEC filing | Newly reported 26'Q2 | $538,944 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market